Illumine Investment Management, LLC

Position in AMPH — Amphastar Pharmaceuticals, Inc.

CIK 2052970 POULSBO, WA

Back to AMPH Full portfolio

Position in AMPH

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$550,048

-$208,575 QoQ

Shares Held

28,078

-0.9% QoQ

Ownership

0.064%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AMPH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Illumine Investment Management, LLC holds $6,405,667 across 3 Drug Manufacturers - Specialty & Generic names. AMPH ranks #3 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	7,735	$4,586,700
2	NBIX	Neurocrine Biosciences Inc	9,632	$1,268,919
3	AMPH	Amphastar Pharmaceuticals, Inc. This page	28,078	$550,048

All Filings in AMPH

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$550,048	28,078	-0.9%	Shares	Sole	2026-05-04
2025-12-31	$758,623	28,328	+2.4%	Shares	Sole	2026-02-09
2025-09-30	$737,592	27,677	+2.0%	Shares	Sole	2025-11-04
2025-06-30	$622,812	27,126	+2.2%	Shares	Sole	2025-08-07
2025-03-31	$769,104	26,530	+55.6%	Shares	Sole	2025-04-22
2024-12-31	$633,029	17,049	—	Shares	Sole	2025-02-05
No filing history on record for this holder in this stock.